'A multicenter double-blind, placebo-controlled randomized pilot study evaluating efficacy and safety of ETN in patients with moderate to severe plaque psoriasis after cessation of ciclosporin therapy'

Trial Profile

'A multicenter double-blind, placebo-controlled randomized pilot study evaluating efficacy and safety of ETN in patients with moderate to severe plaque psoriasis after cessation of ciclosporin therapy'

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2012

At a glance

  • Drugs Etanercept (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Acronyms SCORE
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Oct 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2006-004454-25).
    • 20 Apr 2012 Company added as trial sponsor as reported by ClinicalTrials.gov.
    • 20 Apr 2012 Actual patient number changed from 154 to 120 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top